Cephalexin
- Product NDC
- 10544-020
- 11-digit product format
- 105440020
- Labeler code
- 10544
- Product ID
- 10544-020_9fc0b42f-ecb7-4070-a18c-e57d5a53778a
- Type
- HUMAN PRESCRIPTION DRUG
- Nonproprietary name
- Cephalexin
- Dosage form
- CAPSULE
- Route
- ORAL
- Labeler
- Blenheim Pharmacal, Inc.
- Application
- ANDA062702
- Marketing category
- ANDA
- Marketing start
- 2010-09-28
- Marketing end
- 0000-00-00
- Substance
- CEPHALEXIN
- Active strength
- 500 mg/1
- NDC exclude flag
- E
- Listing certified through
- 2017-12-31
- Current FDA listing
- Historical FDA.report record
DailyMed Product Concepts#
FDA-Initiated Inactive NDC Indexing#
NDC, Effective, Action table| NDC | Effective | Action | Document | Indexing SPL | Related label |
|---|
| 10544-020-10 | 2019-10-29 | C162847 | 48780-1 | 960f7f55-d22c-8e05-e053-dbdaa90a074a | CEPHALEXIN CAPSULES USP, 250 mg and 500 mg / CEPHALEXIN FOR ORAL SUSPENSION USP, 125 mg/5 mL and 250 mg/5 mL / CEPHALEXIN TABLETS USP, 250 mg and 500 mg 3145 3147 4175 4177 2238 2240 Rx only |
| 10544-020-14 | 2019-10-29 | C162847 | 48780-1 | 960f7f55-d22c-8e05-e053-dbdaa90a074a | CEPHALEXIN CAPSULES USP, 250 mg and 500 mg / CEPHALEXIN FOR ORAL SUSPENSION USP, 125 mg/5 mL and 250 mg/5 mL / CEPHALEXIN TABLETS USP, 250 mg and 500 mg 3145 3147 4175 4177 2238 2240 Rx only |
| 10544-020-20 | 2019-10-29 | C162847 | 48780-1 | 960f7f55-d22c-8e05-e053-dbdaa90a074a | CEPHALEXIN CAPSULES USP, 250 mg and 500 mg / CEPHALEXIN FOR ORAL SUSPENSION USP, 125 mg/5 mL and 250 mg/5 mL / CEPHALEXIN TABLETS USP, 250 mg and 500 mg 3145 3147 4175 4177 2238 2240 Rx only |
| 10544-020-28 | 2019-10-29 | C162847 | 48780-1 | 960f7f55-d22c-8e05-e053-dbdaa90a074a | CEPHALEXIN CAPSULES USP, 250 mg and 500 mg / CEPHALEXIN FOR ORAL SUSPENSION USP, 125 mg/5 mL and 250 mg/5 mL / CEPHALEXIN TABLETS USP, 250 mg and 500 mg 3145 3147 4175 4177 2238 2240 Rx only |
| 10544-020-30 | 2019-10-29 | C162847 | 48780-1 | 960f7f55-d22c-8e05-e053-dbdaa90a074a | CEPHALEXIN CAPSULES USP, 250 mg and 500 mg / CEPHALEXIN FOR ORAL SUSPENSION USP, 125 mg/5 mL and 250 mg/5 mL / CEPHALEXIN TABLETS USP, 250 mg and 500 mg 3145 3147 4175 4177 2238 2240 Rx only |
| 10544-020-40 | 2019-10-29 | C162847 | 48780-1 | 960f7f55-d22c-8e05-e053-dbdaa90a074a | CEPHALEXIN CAPSULES USP, 250 mg and 500 mg / CEPHALEXIN FOR ORAL SUSPENSION USP, 125 mg/5 mL and 250 mg/5 mL / CEPHALEXIN TABLETS USP, 250 mg and 500 mg 3145 3147 4175 4177 2238 2240 Rx only |
DailyMed Package Descriptions#
DailyMed Socrata Ingredients#
Ingredient, Type, UNII table| Ingredient | Type | UNII | DailyMed label | SPL version | Uploaded |
|---|
| CEPHALEXIN | ACTIVE INGREDIENT | OBN7UDS42Y | CEPHALEXIN CAPSULE [BLENHEIM PHARMACAL, INC.] | 1 | |
| CEPHALEXIN | ACTIVE MOIETY | OBN7UDS42Y | CEPHALEXIN CAPSULE [BLENHEIM PHARMACAL, INC.] | 1 | |
| ALUMINUM OXIDE | INACTIVE INGREDIENT | LMI26O6933 | CEPHALEXIN CAPSULE [BLENHEIM PHARMACAL, INC.] | 1 | |
| CARBOXYMETHYLCELLULOSE SODIUM | INACTIVE INGREDIENT | K679OBS311 | CEPHALEXIN CAPSULE [BLENHEIM PHARMACAL, INC.] | 1 | |
| D&C YELLOW NO. 10 | INACTIVE INGREDIENT | 35SW5USQ3G | CEPHALEXIN CAPSULE [BLENHEIM PHARMACAL, INC.] | 1 | |
| FD&C BLUE NO. 1 | INACTIVE INGREDIENT | H3R47K3TBD | CEPHALEXIN CAPSULE [BLENHEIM PHARMACAL, INC.] | 1 | |
| FD&C BLUE NO. 2 | INACTIVE INGREDIENT | L06K8R7DQK | CEPHALEXIN CAPSULE [BLENHEIM PHARMACAL, INC.] | 1 | |
| FD&C RED NO. 40 | INACTIVE INGREDIENT | WZB9127XOA | CEPHALEXIN CAPSULE [BLENHEIM PHARMACAL, INC.] | 1 | |
| FERROSOFERRIC OXIDE | INACTIVE INGREDIENT | XM0M87F357 | CEPHALEXIN CAPSULE [BLENHEIM PHARMACAL, INC.] | 1 | |
| GELATIN | INACTIVE INGREDIENT | 2G86QN327L | CEPHALEXIN CAPSULE [BLENHEIM PHARMACAL, INC.] | 1 | |
| MAGNESIUM STEARATE | INACTIVE INGREDIENT | 70097M6I30 | CEPHALEXIN CAPSULE [BLENHEIM PHARMACAL, INC.] | 1 | |
| PROPYLENE GLYCOL | INACTIVE INGREDIENT | 6DC9Q167V3 | CEPHALEXIN CAPSULE [BLENHEIM PHARMACAL, INC.] | 1 | |
| SILICON DIOXIDE | INACTIVE INGREDIENT | ETJ7Z6XBU4 | CEPHALEXIN CAPSULE [BLENHEIM PHARMACAL, INC.] | 1 | |
| SODIUM LAURYL SULFATE | INACTIVE INGREDIENT | 368GB5141J | CEPHALEXIN CAPSULE [BLENHEIM PHARMACAL, INC.] | 1 | |
| SODIUM STARCH GLYCOLATE TYPE A POTATO | INACTIVE INGREDIENT | 5856J3G2A2 | CEPHALEXIN CAPSULE [BLENHEIM PHARMACAL, INC.] | 1 | |
| TITANIUM DIOXIDE | INACTIVE INGREDIENT | 15FIX9V2JP | CEPHALEXIN CAPSULE [BLENHEIM PHARMACAL, INC.] | 1 | |
DailyMed Dashboard NDC Coverage#
NDC, Dashboard title, SPL version table| NDC | Dashboard title | SPL version | Validation | Dashboard ZIP |
|---|
| 10544-020 | CEPHALEXIN CAPSULE [BLENHEIM PHARMACAL, INC.] | 1 | Legacy NDC, 6 package rows | 20101007_12b6bac5-00a3-437b-a172-d4e09c273c8c.zip |
DailyMed RxNorm Mappings#
Packages#
Package NDC, 11-digit format, Description table| Package NDC | 11-digit format | Description | Status |
|---|
| 10544-020-10 | 10544002010 | 10 in 1 BOTTLE | Historical |
| 10544-020-14 | 10544002014 | 14 in 1 BOTTLE | Historical |
| 10544-020-20 | 10544002020 | 20 in 1 BOTTLE | Historical |
| 10544-020-28 | 10544002028 | 28 in 1 BOTTLE | Historical |
| 10544-020-30 | 10544002030 | 30 in 1 BOTTLE | Historical |
| 10544-020-40 | 10544002040 | 40 in 1 BOTTLE | Historical |